Summary

Middle East Ophthalmic Devices Market Summary

The Middle East ophthalmic devices market size was estimated at USD 1.09 billion in 2024 and is projected to reach USD 1.79 billion by 2033, growing at a CAGR of 5.8% from 2025 to 2033. Demographic, economic, and technological factors drive the expanding market.

The region's aging population and the prevalence of chronic conditions such as diabetes lead to a surge in vision-related disorders such as cataracts, glaucoma, and vitreo-retinal disorders. This increasing patient burden, rising health consciousness, and greater access to disposable income generate a strong demand for modern eye care services and the devices that support them. Governments and private entities also invest significantly in healthcare infrastructure, further fueling the growth of the Middle East ophthalmic devices industry. Innovation is a key catalyst for the market's evolution, with a focus on advanced diagnostic and surgical technologies that improve patient outcomes.

The ongoing integration of artificial intelligence (AI) is also a notable trend. These technologies facilitate screening and diagnosis, which is particularly beneficial for extending eye care to patients. For instance, in March 2025, the Oman Ministry of Health launched a national program for diabetic retinopathy screening, equipping 25 healthcare facilities with advanced retinal imaging devices integrated with AI-powered tools. This initiative positioned Oman as the third country globally to execute such a program. By August 2025, the program had already screened over 10,000 patients, demonstrating its success in enhancing the prevention of retinopathy.

Middle East Ophthalmic Devices Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East ophthalmic devices market report based on product, application, end use, and country.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Optical Coherence Tomography Scanners
• Fundus Cameras
• Perimeters/Visual Field Analyzers
• Autorefractors and Keratometers
• Ophthalmic Ultrasound Imaging Systems
o Ophthalmic A-Scan Ultrasound
o Ophthalmic B-Scan Ultrasound
o Ophthalmic Ultrasound Biomicroscopes
o Ophthalmic Pachymeters
• Tonometers
• Slit Lamps
• Phoropters
• Wavefront Aberrometers
• Optical Biometry Systems
• Ophthalmoscopes
• Lensmeters
• Corneal Topography Systems
• Specular Microscopes
• Retinoscopes
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cataract
• Vitreo Retinal Disorders
• Glaucoma
• Refractive Disorders
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Eye Clinics
• Academic and Research Laboratory
• Others
• Country Outlook (Revenue, USD Million, 2021 - 2033)
• Middle East
o Kuwait
o Saudi Arabia
o UAE
o Oman
o Qatar
o Turkey

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumption
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Estimation & Data Visualization
1.6. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook, 2024 (USD Million)
2.2. Segmental Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Country outlook
2.3. Competitive Insights
Chapter 3. Middle East Ophthalmic Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Middle East Ophthalmic Devices Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Middle East Ophthalmic Devices Market: Product Estimates & Trend Analysis
4.1. Key Takeaways
4.2. Product Movement Analysis & Market Share, 2024 & 2033
4.3. Middle East Ophthalmic Devices Market by Product, 2021 - 2033 (USD Million)
4.4. Optical Coherence Tomography Scanners
4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Fundus Cameras
4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Perimeters/Visual Field Analyzers
4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Autorefractors and Keratometers
4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Ophthalmic Ultrasound Imaging Systems
4.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.1.1. Ophthalmic A-Scan Ultrasound
4.8.1.1.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.1.2. Ophthalmic B-Scan Ultrasound
4.8.1.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.1.3. Ophthalmic Ultrasound Biomic
4.8.1.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.1.4. Ophthalmic Pachymeters
4.8.1.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9. Tonometers
4.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.10. Slit Lamps
4.10.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11. Phoropters
4.11.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.12. Wavefront Aberrometers
4.12.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.13. Optical Biometry Systems
4.13.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.14. Ophthalmoscopes
4.14.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.15. Lensmeters
4.15.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.16. Corneal Topography Systems
4.16.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.17. Specular Microscopes
4.17.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.18. Rentinoscopes
4.18.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Ophthalmic Devices Market: Application Estimates & Trend Analysis
5.1. Key Takeaways
5.2. Application Movement Analysis & Market Share, 2024 & 2033
5.3. Middle East Ophthalmic Devices Market by Application, 2021 - 2033 (USD Million)
5.4. Cataract
5.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Vitreo Retinal Disorders
5.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Glaucoma
5.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Refractive Disorders
5.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Ophthalmic Devices Market: End Use Estimates & Trend Analysis
6.1. Key Takeaways
6.2. End Use Movement Analysis & Market Share, 2024 & 2033
6.3. Middle East Ophthalmic Devices Market by End Use, 2021 - 2033 (USD Million)
6.4. Hospitals and Eye Clinics
6.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Academic and Research Laboratory
6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Others
6.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Middle East Ophthalmic Devices Market: Country Estimates & Trend Analysis
7.1. Key Takeaways
7.2. Country Market Share Analysis, 2024 & 2033
7.3. Middle East
7.3.1. Middle East Ophthalmic Devices Market Estimates and Forecasts, By Product, 2021 - 2033 (USD Million)
7.3.2. Middle East Ophthalmic Devices Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million)
7.3.3. Middle East Ophthalmic Devices Market Estimates and Forecasts, By End Use, 2021 - 2033 (USD Million)
7.3.4. Kuwait
7.3.4.1. Market Estimates and Forecasts, By Product, 2021 - 2033 (USD Million)
7.3.4.2. Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million)
7.3.4.3. Market Estimates and Forecasts, By End Use, 2021 - 2033 (USD Million)
7.3.5. Saudi Arabia
7.3.5.1. Market Estimates and Forecasts, By Product, 2021 - 2033 (USD Million)
7.3.5.2. Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million)
7.3.5.3. Market Estimates and Forecasts, By End Use, 2021 - 2033 (USD Million)
7.3.6. UAE
7.3.6.1. Market Estimates and Forecasts, By Product, 2021 - 2033 (USD Million)
7.3.6.2. Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million)
7.3.6.3. Market Estimates and Forecasts, By End Use, 2021 - 2033 (USD Million)
7.3.7. Qatar
7.3.7.1. Market Estimates and Forecasts, By Product, 2021 - 2033 (USD Million)
7.3.7.2. Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million)
7.3.7.3. Market Estimates and Forecasts, By End Use, 2021 - 2033 (USD Million)
7.3.8. Oman
7.3.8.1. Market Estimates and Forecasts, By Product, 2021 - 2033 (USD Million)
7.3.8.2. Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million)
7.3.8.3. Market Estimates and Forecasts, By End Use, 2021 - 2033 (USD Million)
7.3.9. Turkey
7.3.9.1. Market Estimates and Forecasts, By Product, 2021 - 2033 (USD Million)
7.3.9.2. Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million)
7.3.9.3. Market Estimates and Forecasts, By End Use, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Key Players, their Recent Developments, and their Impact on Industry
8.2. Competition Categorization
8.3. Company Market Position Analysis
8.4. Company Heat Map Analysis
8.5. Strategy Mapping, 2024
8.6. Company Listing
8.6.1. Alcon Inc.
8.6.1.1. Company Overview
8.6.1.2. Financial Performance
8.6.1.3. Product Benchmarking
8.6.1.4. Strategic Initiatives
8.6.2. Norlase
8.6.2.1. Company Overview
8.6.2.2. Financial Performance
8.6.2.3. Product Benchmarking
8.6.2.4. Strategic Initiatives
8.6.3. Visionix
8.6.3.1. Company Overview
8.6.3.2. Financial Performance
8.6.3.3. Product Benchmarking
8.6.3.4. Strategic Initiatives
8.6.4. Topcon Healthcare
8.6.4.1. Company Overview
8.6.4.2. Financial Performance
8.6.4.3. Product Benchmarking
8.6.4.4. Strategic Initiatives
8.6.5. Ocular Instruments
8.6.5.1. Company Overview
8.6.5.2. Financial Performance
8.6.5.3. Product Benchmarking
8.6.5.4. Strategic Initiatives
8.6.6. Bausch + Lomb
8.6.6.1. Company Overview
8.6.6.2. Financial Performance
8.6.6.3. Product Benchmarking
8.6.6.4. Strategic Initiatives